{
  "docId": "019de070-1b1e-715b-9181-3c5ed2b300ba",
  "docSlug": "b1852bb8f228b7adee18c4b9e730fd78",
  "documentTitle": "Calliditas Therapeutics | IPO Presentation Deck | 38 slides",
  "authorId": "calliditas-therapeutics",
  "authorName": "Calliditas Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 38,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "Includes checkmarks for completed items; 2020 is marked with an asterisk regarding COVID-19 uncertainty.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-1b1e-715b-9181-3c5ed2b300ba/31",
  "deckHref": "/decks/019de070-1b1e-715b-9181-3c5ed2b300ba",
  "deckJsonHref": "/decks/019de070-1b1e-715b-9181-3c5ed2b300ba.json",
  "deckAnchorHref": "/decks/019de070-1b1e-715b-9181-3c5ed2b300ba#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.92,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Anticipated milestones regarding Calliditas' clinical, regulatory and commercial plans",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc32ab1d-d68f-49c7-b0af-f622faa44c3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.04,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "* Subject to uncertainty due to COVID-19 outbreak.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8bb16f7-1141-445e-a4a6-c42fc3bd17ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Anticipated milestones",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78660a4e-c2be-4d18-b2ec-a4c0653ece7c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "2718f77e-298f-482b-ac18-04943c08b5a1",
      "evidence": "Chronological progression of milestones across time periods.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 32,
      "from": 31,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "6b785561-4009-41a7-ba36-3b1cce235cfa",
      "evidence": "The document presents the anticipated milestones and the potential for Nefecon to be the first approved treatment for IgAN.",
      "position": 1,
      "objective": "Why is now the right time to invest in Nefecon?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}